website statistics

Now Offering Over 102,157 Antibodies & 44,722 Antigens!

ERBB2 Antibody (OAPB00881)

Scroll Horizontally to view all Images
Print Page
  • Let us Help: Ask a Question
0.1 mg
$375.00
In Stock

Conjugation Options

OAPB00881-FITC Conjugated

OAPB00881-HRP Conjugated

OAPB00881-Biotin Conjugated

Gene Symbol:
ERBB2
NCBI Gene Id:
2064
Official Gene Full Name:
Receptor tyrosine-protein kinase erbB-2
Protein Name:
Receptor tyrosine-protein kinase erbB-2
Swissprot Id:
P04626
Replacement Item:
This antibody may replace item sc-08, HPA001383
Description of Target:
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2
Host:
chicken
Clonality:
Polyclonal
Purification:
Affinity chromatography purified via peptide column
Application:
ELISA, WB, IHC-P, IF, IP
Tissue Tool:
Find tissues and cell lines supported by DNA array analysis to express ERBB2.
RNA Seq:
Find tissues and cell lines supported by RNA-seq analysis to express ERBB2.
Immunogen:
The immunogen for anti-erbB-2 antibody: antibody was raised against a 19 amino acid peptide near the carboxy terminus of human erbB-2. The immunogen is located within the last 50 amino acids of erbB-2.
Species Reactivity:
Human, Mouse, Rat
Product Format:
Liquid. PBS with 0.02% sodium azide.
Reconstitution and Storage:
erbB-2 antibody can be stored at 4°C for three months and -20°C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Concentration:
1 mg/ml
Blocking Peptide:
For anti-ERBB2 (OAPB00881) antibody is Catalog # OEPB03003
Datasheets / Downloads:
Printable datasheet for anti-ERBB2 (OAPB00881) antibody
Isotype:
IgY
Application Info:
WB: 1-2 ug/mL
IHC-P: 2.5 ug/mL
IF: 20 ug/mL
:::
Positive Controls: Rat Liver Tissue Lysate
Target Reference:
Baselga J and Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nature Rev.2009; 9:463-475.;Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science1987; 235:177-82.;Vermeij J, Teugels E, Bourgain C, et al. Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers. BMC Cancer2008; 8:3.;Marmor MD, Skaria KB, and Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int. J. Rad. Oncol. Biol. Phys.2004; 58:903-13.
Protocol:
Tips Information:
 
X
Ask a Question

Tell us what you think about this item!

Write A Review
    Please, wait...